Type of prior genotoxic insult determines the genomic characteristics of therapy‐related myeloid neoplasms
Open Access
- 24 March 2021
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 96 (7) , E223-E225
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Cancer therapy shapes the fitness landscape of clonal hematopoiesisNature Genetics, 2020
- Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid LeukemiaGenes, 2020
- Therapy-related myeloid neoplasms: when genetics and environment collideNature Reviews Cancer, 2017
- Emerging therapies for acute myeloid leukemiaJournal of Hematology & Oncology, 2017
- Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort StudyJournal of Clinical Oncology, 2015
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaNature, 2014